3-67609616-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_003848.4(SUCLG2):c.85-20C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.443 in 1,605,558 control chromosomes in the GnomAD database, including 161,771 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.49 ( 18780 hom., cov: 32)
Exomes 𝑓: 0.44 ( 142991 hom. )
Consequence
SUCLG2
NM_003848.4 intron
NM_003848.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.183
Genes affected
SUCLG2 (HGNC:11450): (succinate-CoA ligase GDP-forming subunit beta) This gene encodes a GTP-specific beta subunit of succinyl-CoA synthetase. Succinyl-CoA synthetase catalyzes the reversible reaction involving the formation of succinyl-CoA and succinate. Alternate splicing results in multiple transcript variants. Pseudogenes of this gene are found on chromosomes 5 and 12. [provided by RefSeq, Apr 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 3-67609616-G-A is Benign according to our data. Variant chr3-67609616-G-A is described in ClinVar as [Benign]. Clinvar id is 257603.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.634 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SUCLG2 | NM_003848.4 | c.85-20C>T | intron_variant | ENST00000307227.10 | NP_003839.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SUCLG2 | ENST00000307227.10 | c.85-20C>T | intron_variant | 1 | NM_003848.4 | ENSP00000307432 | P1 | |||
SUCLG2 | ENST00000493112.5 | c.85-20C>T | intron_variant | 1 | ENSP00000419325 | |||||
SUCLG2 | ENST00000492795.1 | c.85-20C>T | intron_variant | 2 | ENSP00000417589 |
Frequencies
GnomAD3 genomes AF: 0.486 AC: 73611AN: 151384Hom.: 18739 Cov.: 32
GnomAD3 genomes
AF:
AC:
73611
AN:
151384
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.414 AC: 101676AN: 245440Hom.: 22285 AF XY: 0.412 AC XY: 54885AN XY: 133266
GnomAD3 exomes
AF:
AC:
101676
AN:
245440
Hom.:
AF XY:
AC XY:
54885
AN XY:
133266
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.438 AC: 636851AN: 1454054Hom.: 142991 Cov.: 32 AF XY: 0.435 AC XY: 314467AN XY: 723506
GnomAD4 exome
AF:
AC:
636851
AN:
1454054
Hom.:
Cov.:
32
AF XY:
AC XY:
314467
AN XY:
723506
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.486 AC: 73686AN: 151504Hom.: 18780 Cov.: 32 AF XY: 0.478 AC XY: 35381AN XY: 74006
GnomAD4 genome
AF:
AC:
73686
AN:
151504
Hom.:
Cov.:
32
AF XY:
AC XY:
35381
AN XY:
74006
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1438
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at